Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study). (Q43234979)
Jump to navigation
Jump to search
scientific article published on 24 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study). |
scientific article published on 24 November 2009 |
Statements
1 reference
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study). (English)
1 reference
N Pérez-Alvarez
1 reference
E Negredo
1 reference
B Clotet
1 reference
P Echeverría
1 reference
G Carosi
1 reference
J Gálvez
1 reference
J L Gómez
1 reference
A Ocampo
1 reference
J Portilla
1 reference
A Prieto
1 reference
J C López
1 reference
R Rubio
1 reference
A Mariño
1 reference
E Pedrol
1 reference
C Viladés
1 reference
A del Arco
1 reference
A Moreno
1 reference
I Bravo
1 reference
R López-Blazquez
1 reference
24 November 2009
1 reference
1 reference
Identifiers
1 reference